Literature DB >> 25126717

The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia.

Ofer Pasternak1, Carl-Fredrik Westin2, Brian Dahlben3, Sylvain Bouix3, Marek Kubicki4.   

Abstract

In a previous study we have demonstrated, using a novel diffusion MRI analysis called free-water imaging, that the early stages of schizophrenia are more likely associated with a neuroinflammatory response and less so with a white matter deterioration or a demyelination process. What is not known is how neuroinflammation and white matter deterioration change along the progression of the disorder. In this study we apply the free-water measures on a population of 29 chronic schizophrenia subjects and compare them with 25 matching controls. Our aim was to compare the extent of free-water imaging abnormalities in chronic subjects with the ones previously obtained for subjects at their first psychotic episode. We find that chronic subjects showed a limited extent of abnormal increase in the volume of the extracellular space, suggesting a less extensive neuroinflammatory response relative to patients at the onset of schizophrenia. At the same time, the chronic schizophrenia subjects had greater extent of reduced fractional anisotropy compared to the previous study, suggesting increased white matter deterioration along the progression of the disease. Our findings substantiate the role of neuroinflammation in the earlier stages of the disorder, and the effect of neurodegeneration that is worsening in the chronic phase.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Degeneration; Free-water; Neuroinflammation; Schizophrenia; White matter

Mesh:

Year:  2014        PMID: 25126717      PMCID: PMC4277709          DOI: 10.1016/j.schres.2014.07.031

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  25 in total

1.  Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.

Authors:  Johann Steiner; Hendrik Bielau; Ralf Brisch; Peter Danos; Oliver Ullrich; Christian Mawrin; Hans-Gert Bernstein; Bernhard Bogerts
Journal:  J Psychiatr Res       Date:  2006-12-15       Impact factor: 4.791

2.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

3.  Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia.

Authors:  S G Fillman; N Cloonan; V S Catts; L C Miller; J Wong; T McCrossin; M Cairns; C S Weickert
Journal:  Mol Psychiatry       Date:  2012-08-07       Impact factor: 15.992

Review 4.  Development, disease and degeneration in schizophrenia: a unitary pathophysiological model.

Authors:  M S Keshavan
Journal:  J Psychiatr Res       Date:  1999 Nov-Dec       Impact factor: 4.791

Review 5.  Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective.

Authors:  J A Lieberman
Journal:  Biol Psychiatry       Date:  1999-09-15       Impact factor: 13.382

Review 6.  Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies.

Authors:  Robyn Honea; Tim J Crow; Dick Passingham; Clare E Mackay
Journal:  Am J Psychiatry       Date:  2005-12       Impact factor: 18.112

Review 7.  A review of diffusion tensor imaging studies in schizophrenia.

Authors:  Marek Kubicki; Robert McCarley; Carl-Fredrik Westin; Hae-Jeong Park; Stephan Maier; Ron Kikinis; Ferenc A Jolesz; Martha E Shenton
Journal:  J Psychiatr Res       Date:  2005-07-14       Impact factor: 4.791

8.  C-reactive protein is elevated in schizophrenia.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Crystal Vaughan; Sunil Khushalani; Shuojia Yang; Robert Yolken
Journal:  Schizophr Res       Date:  2012-12-04       Impact factor: 4.939

Review 9.  White matter changes in schizophrenia: evidence for myelin-related dysfunction.

Authors:  Kenneth L Davis; Daniel G Stewart; Joseph I Friedman; Monte Buchsbaum; Philip D Harvey; Patrick R Hof; Joseph Buxbaum; Vahram Haroutunian
Journal:  Arch Gen Psychiatry       Date:  2003-05

10.  Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study.

Authors:  Natalya A Uranova; Olga V Vikhreva; Valentina I Rachmanova; Diana D Orlovskaya
Journal:  Schizophr Res Treatment       Date:  2011-06-28
View more
  51 in total

1.  Diffusion abnormalities in the corpus callosum in first episode schizophrenia: Associated with enlarged lateral ventricles and symptomatology.

Authors:  Elisabetta C Del Re; Sylvain Bouix; Jennifer Fitzsimmons; Gabriëlla A M Blokland; Raquelle Mesholam-Gately; Joanne Wojcik; Zora Kikinis; Marek Kubicki; Tracey Petryshen; Ofer Pasternak; Martha E Shenton; Margaret Niznikiewicz
Journal:  Psychiatry Res       Date:  2019-02-18       Impact factor: 3.222

2.  Characterizing white matter changes in chronic schizophrenia: A free-water imaging multi-site study.

Authors:  Lena K L Oestreich; Amanda E Lyall; Ofer Pasternak; Zora Kikinis; Dominick T Newell; Peter Savadjiev; Sylvain Bouix; Martha E Shenton; Marek Kubicki; Thomas J Whitford; Simon McCarthy-Jones
Journal:  Schizophr Res       Date:  2017-02-10       Impact factor: 4.939

3.  Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.

Authors:  Yi Hong; Lauren J O'Donnell; Peter Savadjiev; Fan Zhang; Demian Wassermann; Ofer Pasternak; Hans Johnson; Jane Paulsen; Jean-Paul Vonsattel; Nikos Makris; Carl F Westin; Yogesh Rathi
Journal:  Hum Brain Mapp       Date:  2018-05-24       Impact factor: 5.038

Review 4.  In vivo imaging of neuroinflammation in schizophrenia.

Authors:  Ofer Pasternak; Marek Kubicki; Martha E Shenton
Journal:  Schizophr Res       Date:  2015-06-03       Impact factor: 4.939

5.  The contribution of neuroimaging to understanding schizophrenia; past, present, and future.

Authors:  Iris E Sommer; René S Kahn
Journal:  Schizophr Bull       Date:  2014-10-27       Impact factor: 9.306

6.  Alteration of gray matter microstructure in schizophrenia.

Authors:  Johanna Seitz; Yogesh Rathi; Amanda Lyall; Ofer Pasternak; Elisabetta C Del Re; Margaret Niznikiewicz; Paul Nestor; Larry J Seidman; Tracey L Petryshen; Raquelle I Mesholam-Gately; Joanne Wojcik; Robert W McCarley; Martha E Shenton; Inga K Koerte; Marek Kubicki
Journal:  Brain Imaging Behav       Date:  2018-02       Impact factor: 3.978

7.  Dose-dependent white matter damage after brain radiotherapy.

Authors:  Michael Connor; Roshan Karunamuni; Carrie McDonald; Nathan White; Niclas Pettersson; Vitali Moiseenko; Tyler Seibert; Deborah Marshall; Laura Cervino; Hauke Bartsch; Joshua Kuperman; Vyacheslav Murzin; Anitha Krishnan; Nikdokht Farid; Anders Dale; Jona Hattangadi-Gluth
Journal:  Radiother Oncol       Date:  2016-10-21       Impact factor: 6.280

8.  Q-space trajectory imaging for multidimensional diffusion MRI of the human brain.

Authors:  Carl-Fredrik Westin; Hans Knutsson; Ofer Pasternak; Filip Szczepankiewicz; Evren Özarslan; Danielle van Westen; Cecilia Mattisson; Mats Bogren; Lauren J O'Donnell; Marek Kubicki; Daniel Topgaard; Markus Nilsson
Journal:  Neuroimage       Date:  2016-02-23       Impact factor: 6.556

9.  Amyloid burden accelerates white matter degradation in cognitively normal elderly individuals.

Authors:  Ashwati Vipin; Kwun Kei Ng; Fang Ji; Hee Youn Shim; Joseph K W Lim; Ofer Pasternak; Juan Helen Zhou
Journal:  Hum Brain Mapp       Date:  2019-01-03       Impact factor: 5.038

10.  Diffusion Imaging of White Matter In Schizophrenia: Progress and Future Directions.

Authors:  Katherine H Karlsgodt
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.